MACS® GMP Recombinant Human IL-1β
Synonyms: IL1F2

Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that mediates inflammatory responses and displays a wide variety of biological activities on many different cell types, including T cells, B cells, and monocytes.

MACS GMP Recombinant Human IL-1β is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Related products for MACS® GMP Recombinant Human IL-1β

Specifications for MACS® GMP Recombinant Human IL-1β
Overview

Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that mediates inflammatory responses and displays a wide variety of biological activities on many different cell types, including T cells, B cells, and monocytes.

MACS GMP Recombinant Human IL-1β is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Alternative names

IL1F2

Detailed product information

Biological activity

Determination method
The specific activity is determined by proliferation assay according to Poole and Gaines-Das1 using D10.G4.1 cells provided by the German Resource Centre for Biological Material (DSMZ). The proliferation assay was calibrated with the first international reference standard for human IL-1β (NIBSC code 86/680) provided by the National Institute for Biological Standards and Control.
Minimal specific activity
≥ 2×107 IU/mg
Background information

IL-1β is mainly secreted by monocytes and macrophages. IL-1β secretion has also been reported for a variety of other cells, including B cells, NK cells, dendritic cells, astrocytes, and microglial cells. IL-1β acts also on nonimmune system cells such as fibroblasts, vascular endothelial cells, and hepatocytes.

Applications

MACS GMP Recombinant Human IL-1β can be used for a variety of applications, including the ex vivo generation of human dendritic cells from enriched CD14+ monocyte populations.2–4

Technical specifications

  • Identity/ Molecular mass: 17377 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-1β (153 amino acids).
  • Purity: ≥ 97 % as determined by chip electrophoresis.
  • Endotoxin content: < 50 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
  • Residual host cell DNA content: < 5 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
  • Residual host cell protein content: < 0.5 µg/mg, as determined by E. coli HCP ELISA.

The product quality certificate of MACS® GMP Recombinant Human IL-1β was adapted. Learn more here

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Product data and images for MACS® GMP Recombinant Human IL-1β
Figure 1

Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-1β. The peak corresponds to the calculated molecular mass of 17377 Da.

Figure 2

MACS GMP Recombinant Human IL-1β biological activity. Activity of Human IL-1β, GMP grade, (blue bar) was compared to other commercially available products (black and grey bar).

Resources for MACS® GMP Recombinant Human IL-1β
Documents and Protocols
Certificates

Enter the lot number from your product label to access its Product Quality Certificated (PQC).

Get certificate

Citations for MACS® GMP Recombinant Human IL-1β
Publications
  1. Bender, A. et al. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135
  2. Poole, S. and Gaines-Das, R. E. (1991) The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study. J. Immunol. Methods 142: 1-13
  3. Romani, N. et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196: 137-151
  4. Jonuleit, H. et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27: 3135-3142

You have previously chosen International as your location.
What do you want to do?